Jim Rotolo

Jim Rotolo

Company: Sapience Therapeutics Inc.

Job title: Vice President & Head Of Translational Pharmacology & Research


ST101: Preclinical & Phase 1 Results Targeting C/EBPβ 2:30 pm

• Discuss the key goals that were set out entering phase 1 and the rationale behind them • Explain how the preclinical insights led the decision making efforts as Sapience entered phase 1Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.